Hence, both mutant and wild-type IDH enzymes may constitute a cornerstone of tumor aggressiveness and dynamic metabolic plasticity, in primary and secondary GBM, allowing tumor cells to cope with multifactorial stresses. The gene discussed is IDH1; the disease is neoplasm.